Loading clinical trials...
Loading clinical trials...
This placebo-controlled study will assess the safety and efficacy of a 90-day course of treatment with ifetroban for portal hypertension in cirrhotic patients
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Cumberland Pharmaceuticals
NCT02417740 · Cystic Fibrosis, Immunologic Deficiency Syndrome, and more
NCT07439939 · Liver Cirrhosis, Portal Hypertension
NCT06680583 · Liver Cirrhosis, Gastrointestinal Bleeding
NCT07437755 · Liver Cirrhosis With Acute Decompensation
NCT06205992 · Cirrhosis, Liver Portal Hypertension
Tampa General Medical Group
Tampa, Florida
Indiana University
Indianapolis, Indiana
The Ohio State University Wexner Medical Center
Columbus, Ohio
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions